Alnylam Pharmaceuticals total liabilities and share holders equity for the quarter ending March 31, 2025 was $4.214B, a 10.18% increase year-over-year.
Alnylam Pharmaceuticals total liabilities and share holders equity for 2024 was $4.24B, a 10.71% increase from 2023.
Alnylam Pharmaceuticals total liabilities and share holders equity for 2023 was $3.83B, a 7.99% increase from 2022.
Alnylam Pharmaceuticals total liabilities and share holders equity for 2022 was $3.546B, a 2.66% decline from 2021.
Alnylam Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2025 | ALNY